Navigation Links
Lustgarten Foundation Announces 2009 Request for Proposals (RFP)
Date:6/18/2008

RFP Seeks to Make Rapid Advances in Nation's 4th Leading Cancer Killer

BETHPAGE, N.Y., June 18 /PRNewswire/ -- The Lustgarten Foundation for Pancreatic Cancer Research, the largest private foundation dedicated exclusively to supporting pancreatic cancer research, has announced its Year 2009 Request For Proposals (RFP) to identify promising research into pancreatic cancer, the fourth leading cause of cancer deaths in the United States.

The Lustgarten Foundation's annual RFP seeks to make rapid advances in the battle against pancreatic cancer through a combination of cutting edge technology and novel ideas. These one-year, $100,000 grants encourage the best and brightest minds to bring forth their most promising research ideas. To date, The Lustgarten Foundation has awarded more than $20 million in support of innovative research projects, many of which might not otherwise have been realized.

Funding from The Lustgarten Foundation has enabled investigators to establish the 'proof of principle' required to seek large-scale research awards. To date, Lustgarten grantees have received nearly $100 million in additional research awards from such leading institutions as the National Institutes of Health, National Cancer Institute, American Association for Cancer Research and American Cancer Society.

Said Dr. Robert Vizza, President of The Lustgarten Foundation, "We know that research is our best weapon in the fight against pancreatic cancer. When The Lustgarten Foundation was established, less than a dozen researchers focused on the disease. Today, with Lustgarten Foundation support, the pool of pancreatic cancer investigators continues to grow, and many exciting breakthroughs are being realized. Taken together, these advances are paving the way for earlier detection, better treatments and ultimately, a cure for this disease."

About The Lustgarten Foundation

Founded in 1998 through the efforts of Marc Lustgarten, former Vice Chairman of Cablevision, who died of pancreatic cancer in 1999, and Charles F. Dolan, Chairman of Cablevision, The Lustgarten Foundation has awarded grants totaling more than $20 million in support of pancreatic cancer research. For more information regarding the Foundation and the grant application process, contact:

Contact Info

Kerri Kaplan Kimberly Johnke, L.M.S.W.

Executive Director Manager, Public & Patient Information

516.803.2305 516.803.2306

kkaplan@cablevision.com kjohnke@cablevision.com

http://www.lustgarten.org http://www.lustgarten.org


'/>"/>
SOURCE The Lustgarten Foundation for Pancreatic Cancer Research
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Sopranos Star Vincent Pastore Wins 50 Big Ones for Lustgarten Foundation on NBCs The Celebrity Apprentice
2. National Patient Safety Foundation Partners with Vocera Communications
3. R. P. Simmons Family Foundation Pledges $2 Million for New Childrens Hospital of Pittsburgh of UPMC Campus
4. Patient Advocate Foundation Launches Program to Help Uninsured Virginians with Chronic, Debilitating and Life-Threatening Illness Access Quality Healthcare
5. AIDS Healthcare Foundation Applauds City Commissioners Support of Diversity, Urges Call for Mayors Resignation
6. National Osteoporosis Foundation Teams Up With Ladies Home Journal Magazine to Launch a 10-city Mall Walk Tour
7. Judge Rules That Florida Disease Management Program Serving 8,000 HIV/AIDS Patients Should Be Re-bid, Says AIDS Healthcare Foundation
8. The Tug McGraw Foundation Announces 2007 Fundraising Gala
9. The Arthur M. Blank Family Foundation Pushes for Pre-K Expansion in Georgia
10. Cipla, Tell the Truth; AIDS Healthcare Foundation Launches New Ad Campaign
11. Survey From The Partnership and MetLife Foundation Reveals Important Role Todays Grandparents Play in Teens Lives
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... ... March 29, 2017 , ... Wells Pharmacy ... attending prescribers at the upcoming World Congress, in Hollywood Florida April 6-8, 2017. ... recognized as the visionary leader in the training of physicians, scientists, and members ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... insight into the challenges employers face in trying to balance both short-term and ... benefits programs? Adding to the growing complexity, companies are finding that the ...
(Date:3/29/2017)... (PRWEB) , ... March 29, ... ... Manufacturer Alliance (GRMA) is growing as it continues developing an ANSI-approved, consensus-based ... industry. The organization, which plans to publish the first ANSI-approved GMP standard ...
(Date:3/29/2017)... ... March 29, 2017 , ... Curio Wellness , a ... the finalization of the company’s executive management team with prominent executives from both inside ... Curio Wellness’ Chief Operating Officer, Ted Dumbauld , who has more than twenty ...
(Date:3/29/2017)... ... March 29, 2017 , ... The assembly of synthetic DNA ... many repetitive steps and often scientists require many different versions of DNA. Therefore, ... results in a lower error rate and cost saving for reagents and consumables. ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... 2017  Glenmark Pharmaceuticals, a global pharmaceutical company, ... investigational fixed-dose combination of mometasone furoate (25 mcg) ... a nasal spray being studied for the treatment ... a recently completed Phase 3 trial assessing the ... versus mometasone, olopatadine or placebo. "We ...
(Date:3/29/2017)...  Maxor National Pharmacy Services, LLC ("Maxor"), a leading ... Leah Bailey as General Counsel.  Bailey will serve ... With more than 13 years of experience ... on health care, Bailey joins the Maxor team coming ... advised the PBM, Specialty, and Mail Order business areas ...
(Date:3/29/2017)... , March 29, 2017 Varian Medical Systems ... report results for the second quarter of fiscal year 2017 ... 2017.  The news release will be followed by a teleconference ... news release and a link to the conference call webcast ... .  To access the teleconference call and replay: ...
Breaking Medicine Technology: